← Back to Search

Comprehensive Suicide Prevention Protocol for Suicide Risk (SOS Trial)

N/A
Waitlist Available
Led By Edwin D Boudreaux, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients >12 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after the index ed visit
Awards & highlights

SOS Trial Summary

This trial will investigate whether a standardized protocol for suicide prevention, implemented across different care settings, clinical units, and populations, can improve outcomes for patients at risk for suicide.

Who is the study for?
This trial is for individuals over the age of 12 who may be at risk of suicide. It's not open to prisoners or those under 12 years old, nor adults who are unable to give consent.Check my eligibility
What is being tested?
The SOS trial tests a system that includes suicide risk screening, safety planning, and care transition facilitation using Lean Implementation Strategy. The goal is to standardize protocols across various clinical settings and measure outcomes like suicide attempts and emergencies.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not applicable. However, participants might experience emotional discomfort during the process.

SOS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 12 years.

SOS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after the index ed visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after the index ed visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Care transition facilitation
Means restriction counseling
Safety planning
+3 more

SOS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment4 Interventions
The intervention targets will be the following suicide-related clinician behaviors. suicide risk screening safety planning means restriction counseling Post-acute care follow-up calls A Lean Implementation Strategy: The Implementation of the intervention targets guided by Lean; is expected to increase suicide-related clinician behaviors
Group II: No InterventionActive Control1 Intervention
Baseline Retrospective Chart Reviews that are conducted on subjects for the one year period prior to the implementation of the study will serve as the control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Suicide Risk Screening
2016
N/A
~493760
Safety Planning
2019
N/A
~508100
Care transition facilitation
2016
N/A
~493760
A Lean Implementation Strategy
2016
N/A
~508010

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
342 Previous Clinical Trials
482,854 Total Patients Enrolled
7 Trials studying Suicide
88,737 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,195,351 Total Patients Enrolled
112 Trials studying Suicide
663,063 Patients Enrolled for Suicide
Edwin D Boudreaux, PhDPrincipal InvestigatorUniversity of Massachusetts, Worcester
5 Previous Clinical Trials
43,233 Total Patients Enrolled
3 Trials studying Suicide
42,828 Patients Enrolled for Suicide

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there currently an enrollment period for this clinical trial?

"Clinicaltrials.gov indicates that, while this medical trial was initially posted on October 1st 2016, it is no longer enrolling participants. Despite the conclusion of recruitment for this experiment, there are still 168 other active studies searching for patients at present."

Answered by AI
~58089 spots leftby Apr 2025